Linked article This article is commented on by KJ Moise, p. 1687 in this issue. To view this mini commentary visit http://dx.doi.org/10.1111/1471-0528.13097.
Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
Version of Record online: 21 AUG 2014
© 2014 Royal College of Obstetricians and Gynaecologists
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 122, Issue 12, pages 1682–1686, November 2015
How to Cite
Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS. BJOG 2015;122:1682–1686., , , , , .
- Issue online: 26 OCT 2015
- Version of Record online: 21 AUG 2014
- Manuscript Accepted: 9 JUL 2014
- 1Alloimmune Disorders of Pregnancy Anaemia, Thrombocytopenia and Neutropenia in the Fetus and Newborn. Cambridge, UK: Cambridge University Press, 2005. ISBN: 9780521018043., .
- 2NICE. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Technology appraisal guidance 156. 2008. [www.nice.org.uk/guidance/ta156]. Accessed 7 August 2014.
- 6Antenatal determination of fetal rhesus status using free fetal DNA in the maternal circulation before 20 weeks’ gestation: is routine application practical and beneficial? Arch Dis Child Fetal Neonatal Ed 2011;96(Suppl 1):Fa1–16., , , , .